Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Complementary and Alternative Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Effect of crude leaf extract of Osyris quadripartita on Plasmodium berghei in Swiss albino mice

BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201515:184

https://doi.org/10.1186/s12906-015-0715-3

Received: 6 March 2015

Accepted: 9 June 2015

Published: 16 June 2015

Abstract

Background

Continuous emergence of multi-drug-resistant malaria parasites and their rapid spread across the globe warrant urgent search for new anti-malarial chemotherapeutics. Traditional medicinal plants have been the main sources for screening active phytochemicals against malaria. Accordingly, this study was aimed at evaluating the anti-malarial activity of Osyris quadripartita Salzm. Ex Decne., a plant which is used for traditional malaria treatment by local people in different parts of Ethiopia.

Methods

Aqueous, chloroform and methanol crude leaf extracts of the plant have been prepared and tested for acute toxicity and anti-malarial efficacy in Plasmodium berghei (ANKA strain)-infected Swiss albino mice.

Results

At three oral doses of 200, 400 and 600 mg/kg the plant material was safe, chemosuppressive and thus prevented body weight loss, hematological abnormalities and increased mice mean survival time compared to the negative control. The most efficacious extract was that of chloroform which prolonged mean mouse survival past day 11 of infection with all the mice in this group having the highest parasitemia suppression rate (41.3 %, at 600 mg/kg) although parasite clearance was not achieved compared to the standard drug (chloroquine) against the parasite.

Conclusion

The finding supports the traditional use of the plant for the treatment of malaria. However, further confirmatory studies followed by isolation and characterization of the active anti-malarial compound (s) of the plant that is/are responsible for the observed parasite suppression is needed before it is recommended for malaria drug search and discovery.

Keywords

Antimalarial activity Osyris quadripartita in vivo Plasmodium berghei Swiss albino miceEthiopia

Background

Though malaria mortality rates have fallen by 47 % globally and by 54 % in the World Health Organization (WHO) African Region since 2000, about 198 million cases and 584 000 deaths occurred in 2013 showing that malaria is still among the leading human infectious diseases with 90 % of the cases and deaths occurring in Africa [1]. In Ethiopia, although evidences suggest a substantial decline in malaria cases and deaths in recent years compared to the baseline year of 2004, the occurrence of several isolated outbreaks was reported nationwide and the disease remains a major cause of outpatient consultation in the country [2].

Due to climatic changes and coupled-human-natural factors malaria epidemiology is progressively changing putting more people at-risk. Moreover, there is a rapid emergence of drug-resistant Plasmodium strains. For instance, resistance has already been developed against the latest first-line anti-malaria drug, artemisinin, in Asia [3]. Malaria control efforts are further complicated by the increased resistance of mosquito vectors to insecticides [4] together with challenges of having effective anti-malaria vaccines. Thus, there is urgent need to search for effective, easily available, affordable and safe alternative anti-malaria drugs that can be integrated into the existing malaria control interventions to successfully curtail the disease and for its eventual elimination or eradication.

It is well-known that plants have been and are still the mainstay of traditional medicine against malaria and other diseases in resource-limited settings as over one-third of the population in such countries lack access to essential medicines [5]. However, the claimed potency of medicinal plants has to be scientifically evaluated and toxicological studies should be done. Rigorous in vitro and in vivo toxicological investigations are required to determine the type and degree of toxicity, safety and efficacy of plant products in malaria drug research and ultimate discovery as well as to recommend or discourage a plants’ traditional medicinal use.

To this end, various studies have been conducted to evaluate the safety and anti-malarial efficacy of traditionally used plants in Asia and Africa. For example, Ramazani et al. [6] worked on ten Iranian plant species but only - Boerhavia elegans, Solanum surattense and Prosopis juliflora – showed a promising anti-plasmodial activity in vitro and in vivo with no toxicity. Verma et al. [7] reported that Holarrhena antidysenterica and Viola canescens exhibited in vitro anti-plasmodial activity in Himalaya. From sub-Saharan Africa in Burkina Faso [8], promising in vitro anti-plasmodial results were obtained for the plant Dicoma tomentosa with the dichloromethane, diethylether, ethylacetate and methanol extracts demonstrating a high activity. In the same study hot water and hydroethanolic extracts also showed a good activity, which was also confirmed in vivo for all tested extracts.

Despite their wide use in the traditional healthcare, the work that has been done to evaluate the safety and efficacy of Ethiopian traditional medicinal plants is relatively less extensive. A number of traditional medicinal plants remain unevaluated. Osyris quadripartita which is commonly used in Ethiopian traditional medicinal practices [912] and elsewhere in Africa [13] is a case in point. Specifically, the leaf of this plant is used to traditionally treat malaria [14, 15] in Ethiopia and cancer in Algeria [16]. The anti-inflammatory property of a methanol extract of O. quadripartita was demonstrated in effectively reducing increased capillary permeability induced in rats by various chemical mediators [17]. The antioxidant effect of this plant species has also been evaluated and was found to be good [18]. The plant has anti-bacterial and anti-fungal activities [19]. According to this same work, the plant was active against Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa as well as Gram-positives like Staphylococcus aureus. Though its effect was relatively lesser compared to other parallel test extracts the plant crude extract had a comparable efficacy to that of the positive control (gentamicin sulphate). The anti-bacterial and anti-fungal effects of O. quadripartita were confirmed by a latter more comprehensive study [20]. A different species within the genus, Osyris alba, which was tested against Entameba histolytica, Giardia intestinalis and Candida albicans has shown a reasonable effect [21].

Phytochemical studies on the genus Osyris has yielded hexyl and hexenyl derivatives, sesquiterpenes, phenolic acids, flavoinoids, pyrrolizidine and quinolizidine alkaloids, long chain hydrocarbons and fattyacids, triterpenes, dihydro-β-agarofuran sesquiterpenes, phenolics phenyl propanoids and lignans [17, 2126]. However, the possible anti-plasmodial effect of the genus was not tested in vivo and in vitro either. The aim of this study was, therefore, to assess the anti-plasmodial activity and safety threshold of O. quadripartita in Swiss albino mice in an attempt to contribute towards screening traditional medicinal plants for malaria control.

Methods

Plant description

The genus Osyris which includes more than 34 species belongs to the family Santalaceae and the species O. quadripartita Salzm. ex Decne. (locally called qeret in Amharic and wato in Afaan Oromoo) is an evergreen, dioecious tree or shrub reaching a height of 1–7 m with many branches and the branches sometimes pendant [27]. It is hemiparasitic and sometimes opportunistically taps into the root systems of nearby plants and parasitizes them although it can freely grow and survive [28, 29]. The plant which is native to Africa, southwestern Europe and Asia is commonly known as wild tea plant [30]. This plant is widely distributed in Ethiopia [27].

Sample collection

Leaf samples of O. quadripartita were collected in December 2013 from its natural habitat in Wertu kebele around Fiche Town, some 110 km north of Addis Ababa. Previous ethnobatanical studies characterized Fiche and its flora in relation to traditional medicinal values [31, 32]. The collected plant sample for this study was identified and authenticated by the second author who is an ethnobotanist at Aklilu Lemma Institute of Pathobiology, Addis Ababa University (AAU) and the voucher specimen was deposited in the National Herbarium of AAU with voucher number designated as Senait 001/2014.

Preparation of crude plant extracts

The leaf tissues were washed thoroughly with running tap water and each plant material was reduced to smaller fragments. The washed leaves were air dried at a room temperature under shade in the Biomedical Sciences Laboratory, Department of Microbial, Cellular and Molecular Biology (DMCMB); College of Natural Sciences (CNS), AAU and were ground into fine powder using an electric grinder and kept in a tightly closed brown bottle until used for extraction.

The leaf crude extracts of aqueous, 98 % methanol and chloroform were prepared by the established cold maceration technique [33]. Briefly, a 100 g plant extract material was refluxed in 1000 ml of aqueous, methanol or chloroform and the respective mixtures were placed on an orbital shaker (GFL, model 3020, Germany) at 160 revolutions per minute (rpm) for 72 hours. The mixture was first filtered using cotton and then the filtrate was passed through Whatman filter paper №3, 15 cm pore size with retention down to 0.1 μm in liquids (Whatman LTD, England). The methanol and chloroform extracts were concentrated in a rotary evaporator (Buchi type TRE121, Switzerland) at a temperature of 45 °C; whereas the aqueous extract was freeze-dried using centrifugal freeze dryer (Model 5 PS, Christ, England). All the extracts were stored in screw cap vials at −20 °C until used for the in vivo experiment.

Acute toxicity test

The aqueous and methanol extracts of the plant material were dissolved in 10 ml of distilled water (dH2O) and that of chloroform was dissolved in 3 % Tween (T)-80 prior to the actual experiment, the chloroform extract failed to dissolve in dH2O. Individual body weights (BW) of mice were determined and recorded shortly before and after the plant was administered to evaluate its toxicity as per the Organization for Economic Co-operation and Development (OECD) Guidelines for the Testing of Chemicals [34]. For this purpose non-infected female mice aged 6–8 weeks (mean age 7.4 weeks) and weighing 23-38 g (mean weight 28.35 g) were used.

Twenty mice were used by randomly dividing them into four groups of 5 mice per cage. The mice were starved for 3–4 hrs before the experiment began with only water allowed and 1–2 hrs after the extracts were given. Then, the mice in groups 1, 2 and 3 were orally given 1000, 1500 and 2000 mg/kg BW in single dose volume of 0.2 ml of the extract, respectively. The mice in the negative control group received 0.2 ml of dH2O or T-80. Then, the mice were monitored continuously for 1 hr, intermittently for 4 hrs and for a period of 24 hrs for any gross behavioral changes such as rigidity, sleep, mortality and other signs of acute toxicity manifestations, and the follow-up continued for 28 days [35].

Parasite inoculation and anti-malarial assays

Parasite inoculation and maintenance

When working on chloroquine (CQ)-sensitive P. berghei CQ is employed as a standard positive control [36] and in this study a similar study design was followed. Previously maintained Swiss albino mice 5–7 weeks of age were used for the test. CQ-sensitive strain of P. berghei (ANKA strain) previously maintained in the DMCMB animal house were used for the experiment. Female mice having variable parasitaemia level were used as donor animals. The parasitaemia of the donor mice was first determined and parasitized erythrocytes were obtained by cardiac puncture using ethyl ether as anesthesia and sodium citrate (0.5 %) diluted in physiological saline (0.9 %) as an anticoagulant. The dilution was made based on the parasitaemia of the donor mice and the erythrocyte count of normal mice in such a way that 1 ml blood contains 5x107 infected erythrocytes [37]. Each mouse was inoculated by intra-peritoneal injection with a blood suspension (0.2 ml) containing 1x107 parasitized erythrocytes. The parasite was maintained by serial passage of blood from infected mice to non-infected ones on a weekly basis.

Anti-malarial activity

The standard four-day suppressive method was used in screening of the plant extracts [36]. The experimental mice infected with 1x107P. berghei each were randomly divided into nine test groups and three control groups (each for CQ as the standard anti-malarial drug and dH2O or 3 % T-80 as negative controls (NC). The test extracts were prepared in three different doses (200, 400 and 600 mg/kg BW and CQ at 25 mg/kg, and all including the vehicles were given in a volume of 0.2 ml per mouse. The extracts were administered as a single dose per day. Both the extract and the drug were given through intra-gastric route by using a standard intra-gastric tube to ensure safe ingestion.

Chemosuppression

Treatment was started after 3 hrs of infection with P. berghei on day 0 (D0, inoculation day) and was continued daily for four days (i.e. from D0 to D3). On the fifth day (D4) a blood sample was collected from the tail snip of each mouse. Thin smears were prepared, stained with 10 % Giemsa solution and scanned under the light microscope with an oil immersion objective of 100x magnification power following established procedure [38]. Then, the percent suppression of each extract with respect to the control groups and the parasitaemia was determined by counting a minimum of five fields per slide. Percent of suppression (% suppression) and percent parasitaemia (% parasitaemia) were calculated in comparison to the control using the method described by the modified Peters and Robinson formula [39]:
$$ \% Suppression=\frac{\mathrm{parasitasmia}\kern0.5em \mathrm{in}\kern0.5em \mathrm{negative}\kern0.5em \mathrm{control}\hbox{-} \mathrm{parasitasmia}\kern0.5em \mathrm{in}\kern0.5em \mathrm{treated}\kern0.5em \mathrm{group}}{\mathrm{parasitasmia}\kern0.5em \mathrm{in}\kern0.5em \mathrm{negative}\kern0.5em \mathrm{control}}\mathrm{X}\kern0.5em 100. $$
$$ \%\kern0.5em Suppression\kern0.5em =\frac{\mathrm{number}\kern0.5em \mathrm{of}\kern0.5em \mathrm{parasitized}\kern0.5em \mathrm{R}\mathrm{B}\mathrm{C}}{\mathrm{total}\kern0.5em \mathrm{R}\mathrm{B}\mathrm{C}\kern0.5em \mathrm{counted}}\mathrm{X}\kern0.5em 100. $$

Determination of BW change

The BW of each mouse in all the groups was measured before infection (D0) and on D4 in case of treatment, by using a sensitive digital weighing balance (A&D Company LTD, Japan) and mean BW per group was calculated using the formula:
$$ Mean\kern0.5em BW=\frac{\mathrm{mean}\kern0.5em \mathrm{body}\kern0.5em \mathrm{weightof}\kern0.5em \mathrm{mice}\kern0.5em \mathrm{in}\kern0.5em \mathrm{a}\kern0.5em \mathrm{group}\kern0.5em }{\mathrm{total}\kern0.5em \mathrm{number}\kern0.5em \mathrm{of}\kern0.5em \mathrm{mice}\kern0.5em \mathrm{in}\kern0.5em \mathrm{that}\kern0.5em \mathrm{group}}. $$

Determination of packed cell volume

Packed cell volume (PCV) was determined using blood collected from tail of each mouse in heparinized microhaematocrit capillary tubes (Globe Scientific Inc, Paramus, NJ, USA) and filled up to 3/4th of the tube with blood, sealed one end with crystal seal and placed with the open end of the tube to the center and the sealed end outwards of a microhaematocrit reader (Hawsksley & Sons LTD, England). The blood was centrifuged at 12,000 rpm for 5 min and then the volume of the total blood and the volume of erythrocytes were measured using a ruler. Measurement was done before infection and on D4 after infection. PCV was calculated using the formula described by Gilmour and Sykes [40]:
$$ \mathrm{P}\mathrm{C}\mathrm{V}=\frac{\mathrm{volume}\kern0.5em \mathrm{of}\kern0.5em \mathrm{total}\kern0.5em \mathrm{erythrcytes}\kern0.5em \mathrm{in}\kern0.5em \mathrm{a}\kern0.5em \mathrm{given}\kern0.5em \mathrm{volume}\kern0.5em \mathrm{of}\kern0.5em \mathrm{blood}}{\mathrm{total}\kern0.5em \mathrm{blood}\kern0.5em \mathrm{volume}}\mathrm{x}\kern0.5em 100. $$

Determination of mean survival time

Mortality was monitored daily and the number of days from parasite inoculation up to death was recorded for each mouse in the treatment and control groups throughout the follow-up period. The mean survival time (MST) for each group was calculated using the formula below:
$$ MST=\frac{\mathrm{sum}\kern0.5em \mathrm{of}\kern0.5em \mathrm{survival}\kern0.5em \mathrm{time}\kern0.5em \left(\mathrm{days}\right)\kern0.5em \mathrm{of}\kern0.5em \mathrm{mice}\kern0.5em \mathrm{in}\kern0.5em \mathrm{a}\kern0.5em \mathrm{group}}{\mathrm{total}\kern0.5em \mathrm{number}\kern0.5em \mathrm{of}\kern0.5em \mathrm{mice}\kern0.5em \mathrm{in}\kern0.5em \mathrm{that}\kern0.5em \mathrm{group}}. $$

Ethical considerations

The study was conducted after ethical clearance was obtained from CNS Institutional Ethics Review Board, AAU. The living area for mice allowed them to satisfy their basic needs including the ability to eat, drink, urinate, defecate and also regulate their body temperature. Overall there was a humane handling of the experimental mice throughout the study.

Data analysis

The PCV and BW of P. berghei-infected mice in each group that were treated with the same extracts and dose were compared between D0 and D4, the results were expressed as mean plus or minus the standard error of the mean (M ± SEM) by one way analysis of variance (ANOVA) and 2-tailed Student’s t-test using statistical package for the social sciences (SPSS) version 15 software (SPSS IBM, Chicago, IL, USA). The suppressive test results were analyzed by ANOVA followed by Tukey-multiple comparison test to compare the level of parasitaemia, and survival times of the infected mice between the control group and the extract treated groups at a fixed time. All the data were analyzed at a 95 % confidence interval. P-value less than 0.05 was considered as statistically significant and <0.01 as highly significant.

Results

Extraction yield

The methanol extract of the plant material was the highest yield followed by the aqueous and chloroform extracts (Table 1). The differences between the yields were significant.
Table 1

Yield of aqueous, chloroform and methanol crude leaf extracts ofO. quadripartita

Solvent

Plant powder (g)

Extraction solvent (ml)

Yield (g)

Yield (%)

Aqueous

100

1000

6.60

6.60*

Methanol

100

1000

32.75

32.75*

Chloroform

100

1000

1.447

1.447*

Key: ml = milliliter; g = gram; % = percentage; * = there was significant difference between these values (P < 0.05)

Acute toxicity test

The experimental mice who ingested crude leaf extracts of the three solvents did not show any indication of gross physical or behavioral changes such as hair erection, reduction in feeding and motor activities, weight loss, lacrimation, diarrhea, depression or abnormal secretions within the 24 hrs monitoring period. No fatalities occurred within the observation period of two weeks.

Anti-malarial activity

Effect of crude leaf extracts on PCV and BW

The aqueous, chloroform and methanol leaf extracts of O. quadripartita demonstrated a dose-dependent effect on the mean PCV value of P. berghei-infected mice (Table 2). With increasing dose percentage change in PCV reduction was lowered for all the three extracts. Also, irrespective of extract type and dose there was reduction on mean PCV on D4 though the difference was significant only for the 200 mg/kg the aqueous, and 200 and 400 mg/kg methanol extracts. But, when the results were compared with the NC only 600 mg of the aqueous extract showed a significant mean PCV reduction (p = 0.01).
Table 2

Effect of crude aqueous, methanol and chloroform leaf extracts of O. quadripartita on PCV and BW of O. quadripartita on P. berghei-infected mice

Description

Dose (mg/kg/day)

PCV

BW (g)

D0

D4

% change

p-value**

D0

D4

% change

p-value**

Aqueous

200

60.4 ± 0.60

56.0 ± 0.89a

−7.28

0.02, 0.05

31.2 ± 0.37

26.5 ± 0.76 a

−15.06

0.000, 1.000

400

56.6 ± 1.28

54.0 ± 1.14

−4.59

0.17, 0.34

25.2 ± 0.37

21.8 ± 0.58 a

−13.49

0.000, 0.005

600

58.6 ± 2.02

56.8 ± 1.98*

−3.07

0.34, 0.01

28.6 ± 0.40

25.1 ± 0.47 a

−12.23

0.000, 0.000

Methanol

200

58.4 ± 1.77

54.2 ± 1.46 a

−7.19

0.02, 0.29

30.6 ± 0.40

26.4 ± 0.24 a

−13.72

0.000, 1.000

400

57.0 ± 1.60

53.2 ± 1.20 a

−6.67

0.04, 0.59

28.2 ± 0.37

24.6 ± 0.40 a

−12.76

0.000, 0.522

600

59.4 ± 0.40

55.8 ± 0.73

−6.06

0.06, 0.06

25.6 ± 0.40

23.2 ± 0.37a

−09.37

0.000, 0.112

Chloroform

200

57.2 ± 1.59

54.2 ± 1.31

−5.24

0.11, 0.29

27.6 ± 0.24

26.2 ± 0.37*

−05.07

0.027, 0.000

400

56.4 ± 0.75

55.0 ± 0.54

−2.48

0.46, 0.34

28.6 ± 0.50

30.8 ± 0.58*

+07.69

0.001, 0.000

600

54.8 ± 1.24

53.8 ± 1.52

−1.82

0.59, 0.17

27.0 ± 0.31

29.6 ± 0.40*

+09.62

0.000, 0.000

dH2O (NC)

0.2 ml

56.8 ± 1.93

52.2 ± 1.71 a

−8.09

0.017

29.0 ± 0.31

23.6 ± 0.24 a

−18.62

0.000

T-80 (NC)

0.2 ml

58.0 ± 1.51

52.4 ± 0.92 a

−9.65

0.004

28.8 ± 0.48

23.0 ± 0.44 a

−20.13

0.000

CQ

25

56.8 ± 0.96

56.8 ± 0.89*

0.00

0.674

29.8 ± 0.48

33.2 ± 0.37*a

+11.40

0.000

Keys: Values for the packed cell volume (PCV) and body weight (BW) are presented as mean (M) ± standard error of the mean (SEM); n = 5 (number of mice/group in a single experiment); D0: day 0 (day-of-extract-inoculation); D4 = day 4 (the fifth day pos-extract-inoculation; mg/kg/day: 1mg of extract per one kilogram of mice for one day; NC: negative control; T-80 = Tween-80 (NC for chloroform extract); dH2O: distilled water (NC for aqueous and methanol extract); CQ: chloroquine phosphate; *: significant compared with that of NC; a: significant difference between D0 and D4. **the first value is for the comparison between D0 and D4, the second is with the NC

A loss in BW was noticed for all groups of P. berghei-infected mice four days post-extract-inoculation except for those that ingested 400 and 600 mg/kg chloroform extract. However, the percentage change in BW loss decreased in a dose-dependent manner for all the three extracts at the three doses. In the three groups of infected mice that ingested the three different doses of the aqueous and methanol extracts a significant BW loss was recorded on D4 compared D0, but for the chloroform the difference was not significant. On the other hand; while compared to the NC the change in BW (for all the three doses) was significant for chloroform extract, it was not so for the other two. The infected mice that were treated with 400 and 600 mg/kg chloroform extract significantly gained BW.

Effect of crude leaf extracts on parasitaemia

Although there was clear regression of parasitaemia among aqueous or methanol extract-treated mice, compared to the NC, the difference was statistically significant (p < 0.05) only for the methanol extract at 600 mg/kg dose. With regard to the chloroform extract, however, there was significant decline in % parasitaemia at all the three doses in a dose-dependent manner. The maximum parasitaemia reduction was 38.26 % (for the 600 mg) compared to the figure for the NC group (65.4 %). The evidence showed that the chloroform extract, was significantly associated with lowered parasitaemia compared to the NC as well as the other two concurrently tested extracts although the mice had still microscopically detectable parasitaemia.

Correspondingly, in all groups of extract-treated-mice parasitaemia were increasingly chemosuppressed in a dose-dependent manner with the highest suppression being for the chloroform extract - the highest (41.26 %, at 600 mg/kg dose), mild (37.5 %, at 400 mg/kg), and the least (31.7 %, at 200 mg/kg).

Similarly, for the aqueous and methanol extracts all the three doses, except that of aqueous at 200 mg/kg, were correlated with significantly increased mice survival compared to the NC (dH20). The MST of chloroform extract-treated mice was also significantly higher compared to the NC (3 % T-80) groups and it was prolonged in a dose-dependent manner (Table 3).
Table 3

Chemosuppressive effect of crude aqueous, chloroform and methanol leaf extracts of O. quadripartita in P. berghei-infected mice

Description

Dose (mg/kg/day)

% parasitaemia

p-value

% suppression

MST ± SEM

p-value

Aqueous

200

63.02 ± 3.91

0.740

0.37

6.2 ± 0.37

0.418

400

54.62 ± 2.20

0.142

16.53

7.4 ± 0.51*

0.018

600

51.26 ± 2.05

0.056

21.67

8.2 ± 0.37*

0.001

Methanol

200

55.92 ± 0.84

0.196

14.5

7.4 ± 0.51*

0.018

400

50.94 ± 1.24

0.510

22.16

8.2 ± 0.37*

0.001

600

49.48 ± 2.06*

0.033

24.4

8.4 ± 0.24*

0.000

Chloroform

200

44.48 ± 10.18*

0.006

31.7

8.0 ± 1.14*

0.004

400

40.7 ± 9.66*

0.001

37.5

9.8 ± 0.58*

0.000

600

38.26 ± 8.78*

0.001

41.26

11 ± 0.63*

0.000

DH2O (NC)

0.2 ml

65.44 ± 1.7

-

0.00

5.6 ± 0.24

 

T-80 (NC)

0.2 ml

65.14 ± 1.7

-

0.00

5.8 ± 0.37

 

CQ

25

0.00

0.000

100

ND

 

Keys: mg/kg/day: 1 mg of extract per one kilogram of mice for one day; MST: mean survival time; SEM: standard error of the mean; NC: negative control; T-80 = Tween-80 (NC for chloroform extract); dH2O: distilled water (NC for aqueous and methanol extract); CQ: chloroquine phosphate; ND: no death *: significant compared with that of NC

Discussion

While methanol yielded significantly higher extraction efficiency, the chloroform extract was the lowest. The probable reason for this variation could be due to high concentration of polar compounds in the leaf of the plant species that better dissolve in methanol which is a polar solvent. The quality and quantity of phytochemicals extracted from plant materials differ depending on, among other factors, the solvent type used. The comparative ability of extraction solvents of penetrating the cellular membrane to extract the intracellular ingredients from the plant material may impact extract yield. Some reports show that methanol extracts more number and types of compounds in plant materials than other extraction solvents such as aceton, chloroform, ether, water and ethanol [41]. While chloroform is preferred to extract terpenoids and flavonoids water is employed to solubilize a wide range of plant metabolites like anthocyanins, starches, tannins, saponins, terpenoids, polypeptides and lectins. Methanol releases more diverse phytochemicals such as anthocyanins, tannins, saponins, terpenoids, xanthoxylines, totarol, quassinoids, lectones, flavones, phenols and polyphenols [42].

The finding that the 3 % T-80, which was used as a NC (for the chloroform extract) in the present study and in which the extract was dissolved to deliver to the mice, neither suppressed malaria parasitaemia in the infected mice nor prevented weight loss and PCV depletion indicated lack of possible T-related effect on the malaria parasites.

Oral administration of the methanol, aqueous and chloroform extracts of O. quadripartita did not show changes in the general appearance or behavioral pattern of the experimental mice until the end of 14 days. Further, no death was observed in the animals receiving the extract up to a dose of 2000 mg/kg BW, which is about 10 times the minimum effective dose tested (200 mg/kg). If a test substance has a lethal dose (LD50) higher than 3 times the minimum effective dose, it can be a good candidate for further studies [43]. Therefore, absence of mortality up to an oral dose of 2000 mg/kg could indicate that the test extracts were safe and this could explain the routine use of the plant by the local people for traditional management of malaria.

Significant BW increase among P. berghei-infected mice four days after ingesting 400 and 600 mg chloroform crude leaf extract of O. quadripartita compared to the untreated controls suggests the effect of the extract in preventing malaria-related weight loss. It is well-established that BW loss is one feature of murine malaria [44]. The present result is in agreement with other similar studies that reported mice BW loss using different plant products and extraction solvents [4547]. Lack of significant reduction in the mean BW among aqueous and methanol extract-fed infected mice four days post-treatment further signifies the positive effect of the plant material on mice BW.

The absence of significant PCV reduction among extract-treated mice at the doses of 200 and 400 mg/kg of the aqueous extract may indicate the protective activity of the crude extract. Furthermore, observing a significantly lower PCV reduction among the same groups of mice at the highest dose (600 mg/kg) shows the presence of anti-malarial chemicals in the dose administered. But it appears that the activity of the methanol extract was not strong enough to significantly prevent PCV reduction among P. berghei-infected mice. On the contrary, the PCV of chloroform extract-treated mice remained not significantly changed on D4, irrespective of dose, underlining the protective role of the extract against malaria.

The influence of malaria on hematological parameters is extensively investigated and PCV reduction is considered a hallmark of both human and rodent malaria (reviewed in Lamikanra et al. [48]. Infected mice may suffer from severe malarial anemia because of rapid erythrocyte destruction, either by parasitaemia and/or spleen reticulo-endothelial cells. For instance, in one study it was noted that within an estimated 48 hrs of post-infection rodent PCV was depleted to 43-44 % [49]. Further, P. berghei increased erythrocyte fragility and led to subsequent reduction of PCV in infected-mice [50].

Multiple other in vivo studies on rodent malaria using diverse plant species from Ethiopia as well as abroad have reported similar results [6, 4547, 51, 52]. Scarcity of previous reports pertaining to anti-malarial activity of O. quadripartita including the relative composition and predominance of its leaf chemicals could not permit a discussion from comparative perspective. Although the antimicrobial [19, 20] and antiparasitic activities [21] of O. quadripartita were investigated to some extent, its plasmodial effect was little explored.

The 4-day suppressive test is a standard test commonly used for in vivo anti-malarial phytochemical screening in which ≥30 % reduction in parasitaemia following treatment makes a product to be considered active [36, 43]. Accordingly, the chloroform extract of O. quadripartita which showed 31.7 % suppression at the lowest, 37.5 % at the medium and 41.26 % at the highest doses can be classified as active. The dose-dependent variation in chemosuppression could be attributed to the low concentration of schizocidal compounds in natural products and as such their activity may be undetectable in lower doses. This increased percent suppression of parasitaemia with increased dose was observed by other studies on different plant species [45, 47, 53].

However, both the aqueous and methanol extract of O. quadripartita didn’t display comparable suppressive activity on P. berghei even at the highest dose delivered (600 mg/kg). This at least undetectable level of anti-malarial activity of aqueous and methanol crude leaf extract of O. quadripartita may be an indication that the active ingredients extracted by these solvents might have less potent anti-malarial property. This can be explained by the fact that some plants may contain chemicals that are more soluble in polar solvents such as water, ethanol and methanol while others contain chemicals that are more soluble in non-polar solvents such as chloroform. Thus, the crude aqueous or methanol extracts in the current study were higher in terms of yield but they contained little compounds that were efficacious at least against P. berghei.

A prolonged MST with significant difference, compared to the NC, was observed for mice treated with all the three extracts regardless of dose except for 200 mg/kg of the aqueous extract implying the role of the plant material in the control of murine malaria. Particularly, the chloroform extract was highly associated with prolonged MST even at the minimum dose implicating the dominant presence of antimalarial bioactive compounds of the plant tissue in this extract.

Nevertheless, the chloroform extract itself was less effective compared to CQ, the standard drug against P. berghei. CQ treatment (25 mg/kg) during the infection seemed radically cleared parasitaemia or at least there was no microscopically detectable parasitaemia. Rodent malaria clinical manifestation like diarrhea, lethargy, piloerection, reduced locomotor activity, etc. were non-existent among the CQ-treated showing that the parasitological cure was clinical as well. Mice were appearing and acting healthy on day 28. The undetectable level clearance of parasitaemia following the CQ chemotherapy indicates that the P. berghei strain used in the study was highly sensitive to the drug and lends support that this rodent malaria model system remains effective for in vivo anti-malarial testing.

Conclusions

When orally administered, no adverse effects were noted for the plant extracts ranging from 1000-2000 mg/kg doses signifying the safety of the extracted phytochemicals in mice via the oral route. The aqueous and methanolic extracts showed some parasite suppressive effects on P. berghei-infected mice in a dose-related fashion and the chloroform extract was observed to have the strongest activity although its effect was not comparable to that of the standard drug which achieved parasite clearance to undetectable level microscopically. The anti-plasmodial activity as well as lack of toxicity of the crude extract found in the present study may partly confirm the claim by traditional practitioners about the use of the plant against malaria. However, the finding is only preliminary; and thus confirmatory studies followed by isolation and characterization of the active anti-malarial compound (s) of the plant that is/are responsible for the observed parasite suppression thereby resulting in increased MST, BW loss prevention and PCV reduction in the P. berghei-infected mice are recommended.

Abbreviations

AAU: 

Addis Ababa University

ANOVA: 

Analysis of Variance

BW: 

Body Weight

CQ: 

Chloroquine

D0: 

Day zero

D4: 

Day four

dH2O: 

Distilled water

DMCMB: 

Department of Microbial, Cellular and Molecular Biology

LD: 

Lethal Dose

M ± SEM: 

Mean plus or minus Standard Error of the Mean

MST: 

Mean Survival Time

NC: 

Negative Control

ND: 

No Death

OCED: 

Organization for Economic Cooperation and Development

PCV: 

Packed Cell Volume

% parasitaemia: 

Percentage Parasitaemia

% suppression: 

Percentage Suppression

rpm: 

revolutions per minute

T-80: 

Tween-80

WHO: 

World Health Organization

Declarations

Acknowledgments

The study received financial support from the Office of Academic Vice President through DMCMB, CNS, AAU.

Authors’ Affiliations

(1)
Department of Microbial, Cellular and Molecular Biology, College of Natural Sciences, Addis Ababa University
(2)
Aklilu Lemma Institute of Pathobiology, Addis Ababa University

References

  1. WHO. World Malaria Report 2014. Geneva, Switzerland: World Health Organization; 2014.Google Scholar
  2. FMoH. National malaria program monitoring and evaluation plan 2014–2020. federal democratic republic of Ethiopia ministry of health. Addis Ababa: Federal Ministry of Health; 2014.Google Scholar
  3. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–23.View ArticlePubMedPubMed CentralGoogle Scholar
  4. WHO. Global plan for insecticide resistance management in malaria vectors. Geneva: WHO; 2012.Google Scholar
  5. WHO. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: WHO; 2007.Google Scholar
  6. Ramazani A, Zakeri S, Sardari S, Khodakarim N, Djadidt ND. In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense. Malar J. 2010;9:124.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Verma G, Dua VK, Agarwal DD, Atul PK. Anti-malarial activity of Holarrhena antidysenterica and Viola canescens, plants traditionally used against malaria in the Garhwal region of north-west Himalaya. Malar J. 2011;10:20.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Jansen O, Tits M, Angenot L, Nicolas JP, Mol PD, Nikiema JB, et al. Anti-plasmodial activity of Dicoma tomentosa (Asteraceae) and identification of urospermal A-15- O-acetate as the main active compound. Malar J. 2012;11:289.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Mirutse G, Teklehaymanot T, Animut A, Mekonnen Y. Medicinal plants of the Shinasha, Agew-awi and Amhara peoples in northwest Ethiopia. J Ethnopharmacol. 2007;110:516–25.View ArticleGoogle Scholar
  10. Mesfin F, Demisse S, Teklehaymanot T. An ethnobotanical study of medicinal plants in Wonago Woreda. SNNPR Ethiop J Ethnobiol Ethnomed. 2009;5:28.View ArticleGoogle Scholar
  11. Lulekal E, Kelbessa E, Bekele T, Yineger H. An ethnobotanical study of medicinal plants in Mana Angetu District, southeastern Ethiopia. J Ethnobiol Ethnomed. 2008;4:10.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Lulekal E, Asfaw Z, Kelbessa E, Van Damme P. Ethnomedicinal study of plants used for human ailments in Ankober District, North Shewa Zone. Amhara Region Ethiop J Ethnobiol Ethnomed. 2013;9:63.View ArticleGoogle Scholar
  13. Watt JM, Breyer-Brandwijk MG. The medicinal and poisonous plants of southern and eastern Africa. E. & S. Livingstone Ltd: Edinburg and London; 1962.Google Scholar
  14. Belayneh A, Bussa NF. Ethnomedicinal plants used to treat human ailments in the prehistoric place of Harla and Dengego Valley, eastern Ethiopia. J Ethnobiol Ethnomed. 2014;10:18.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Enyew A, Asfaw Z, Kelbessa E, Nagappan R. Status of medico-cultural commercial plants at Fiche town market, Ethiopia. Int J Pharm & H Care Res. 2013;1(4):227–36.Google Scholar
  16. Rached W, Malika MAB. Evaluation of antioxidant activity and phytochemical analysis of Osyris quadripartita. Nat Prod Chem Res. 2014;2(5):229.Google Scholar
  17. Gómez ME, Ayuso MJ, Toro MV. Activity of Osyris quadripartita salzm. methanol extract on capillary permeability in rats. Phytother Res. 1995;9(7):528–30.View ArticleGoogle Scholar
  18. Rached W, Benamar H, Bennaceur M, Marouf A. Screening of the antioxidant potential of some Algerian indigenous plants. J Biol Sci. 2010;10(4):316–24.View ArticleGoogle Scholar
  19. Taddese S, Asres K, Gbre-Mariam T. In vivo antimicrobial activities of some selected topically applied medical plants. Ethiop Pharma J. 2003;21:39–41.Google Scholar
  20. Geyid A, Abebe D, Debella A, Makonnen Z, Aberra F, Teka F, et al. Screening of some medicinal plants of Ethiopia for their anti-microbial properties and chemical profiles. J Ethnopharmacol. 2005;97:421–7.View ArticlePubMedGoogle Scholar
  21. Al-Jaber HI, Mosleh IM, Mallouh A, Abu Salim OM, Abu Zarga MH. Chemical constituents of Osyris alba and their antiparasitic activities. J Asian Nat Prod Res. 2010;12(9):814–20.View ArticlePubMedGoogle Scholar
  22. Woldemichael GM, Wink M. Concomitant occurrence of pyrrolizidine and quinolizidine alkaloids in hemiparasite Osyris alba L. (Santalaceae). Biochem Syst Ecol. 2002;30:139–49.View ArticleGoogle Scholar
  23. Demirici F, Baser KHC. The volatiles of fresh-cut Osyris alba L. flowers. Flavour Fragr J. 2004;19:72–3.View ArticleGoogle Scholar
  24. Kreipl AT, Konig WA. Sesquiterpenes from the east African sandalwood Osyris tenuifolia. Phytochemistry. 2004;65:2045–9.View ArticlePubMedGoogle Scholar
  25. Yeboah EMO, Majinda RRT, Kadziola A, Muller A. Dihydroxy-beta-agarofuran Sesquiterpenes and Pentacyclic Triterpenoids from the Root Bark of Osyris lanceolata. J Nat Prod. 2010;73:1151–5.View ArticlePubMedGoogle Scholar
  26. Shyaula SL, Manandhar MD, Choudhary MI. Lignans from the Nepalese sandal wood Osyris wightiana Wall ex Wight. J Nepal Chem Soc. 2011;28:24–8.Google Scholar
  27. Hedberg I, Edwards S. The flora of Ethiopia: Pittosporaceae to Araliacae. In: Hedberg I, Edwards S, editors. Flora of Ethiopia. Ethopia: Addis Ababa: National Herbarium, Biology Department, Science Faculty, Addis Ababa University; 1989 [vol. 3].Google Scholar
  28. Herrera CM. The annual cycle of Osyris quadripartita, a hemiparasitic dioecious shrub of Mediterranean scrublands. J Ecol. 1984;74:1065–75.View ArticleGoogle Scholar
  29. Herrera CM. Plant size, spacing patterns, and host-plant selection in Osyris quadripartita, a hemiparasitic dioecious shrub. J Ecol. 1988;76(4):995–1006.View ArticleGoogle Scholar
  30. USDA Germplasm Resources Information Network (GRIN) [www.ars-grin.gov/cgi-bin/npgs/html/taxon.pl].
  31. Enyew A, Asfaw Z, Kelbessa E, Nagappan R. Ethnobotanical study of traditional medicinal plants in and around Fiche District, central Ethiopia. Curr R J Biol Sci. 2014;6(4):154–67.Google Scholar
  32. d’Avigdor E, Wohlmuth H, Asfaw Z, Awas T. The current status of knowledge of herbal medicine and medicinal plants in Fiche. Ethiopia J Ethnobiol Ethnomed. 2014;10:38.View ArticlePubMedGoogle Scholar
  33. O‘Neill MJ, Bray DH, Boardman P, Phillipson JD, Warhurst DC. Plants as source of antimalarial drugs. Part 1. In vitro test method for the evaluation of crude extracts from plants. Planta Med. 1985;61:394–8.View ArticleGoogle Scholar
  34. Organization for Economic Co-operation and Development: OECD Guidelines for the testing of chemicals. Paris; 2008.Google Scholar
  35. Organization for Economic Co-operation and Development: OECD guideline for testing of chemicals. Acute oral toxicity – Up-and-Down Procedure. Paris; 2001.Google Scholar
  36. Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov. 2004;3:509–20.View ArticlePubMedGoogle Scholar
  37. Moll K, Ljungström I, Perlmann H, Scherf A, Wahlgren M. Methods in malaria research. Virginia: Manassas; 2008.Google Scholar
  38. WHO: Basic malaria microscopy. Part I Learners Guide. Geneva; 2010.Google Scholar
  39. Peters W, Robinson BL. The chemotherapy of rodent malarial. Studies on puronaridine and other manich base antimalarials. Annals Trop Med Parasitol. 1992;86:455–65.Google Scholar
  40. Gilmour D, Sykes AJ. Western and Wintrobe methods of estimating ESR compared. Br Med J. 1951;2(4746):1496–7.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Tiwari P, Kumar B, Kaur M, Kaur G, Kaur H. Phytochemical screening and extraction: a review. Intern Pharma Sc. 2011;1(1):98–106.Google Scholar
  42. Cowan MM. Plant products as antimicrobial agents. Clin Microb Rev. 1999;12:564–82.Google Scholar
  43. Krettli AU, Adebayo JO, Krettli LG. Testing of natural products and synthetic molecules aiming at new antimalarials. Curr Drug Targ. 2009;10:261–70.View ArticleGoogle Scholar
  44. Timms R, Colegrave N, Chan BHK, Read AF. The effect of parasite dose on disease severity in the rodent malaria Plasmodium chabaudi. Parasitol. 2001;123:1–11.View ArticleGoogle Scholar
  45. Mohammed T, Erko B, Giday M. Evaluation of antimalarial activity of leaves of Acokanthera schimperi and Croton macrostachyus against Plasmodium berghei in Swiss albino mice. Compl Altern Med. 2014;14:314.View ArticleGoogle Scholar
  46. Amelo W, Nagpal P, Makonnen E. Antiplasmodial activity of solvent fractions of methanolic root extract of Dodonaea angustifolia in Plasmodium berghei infected mice. Compl Altern Med. 2014;14:462.View ArticleGoogle Scholar
  47. Eyasu M, Shibeshi W, Giday M. In vivo antimalarial activity of hydromethanolic extract of Calprnia auriea (Fabaceae) in mice infected with chloroquine-sensitive Plasmodium berghei. Intern J Pharm Pharmacol. 2013;2(9):131–42.Google Scholar
  48. Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ. Malaria anemia of mice and men. Am Soc Hematol. 2007;110(1):18–28.Google Scholar
  49. Taylor PJ, Hurd H. The influence of host haematocrit on the blood feeding success of Anopheles stephensi: implications for enhanced malaria transmission. Parasitol. 2001;122:491–6.View ArticleGoogle Scholar
  50. Iyawe HOT, Onigbinde AO. Impact of Plasmodium berghei and chloroquine on haema antioxidant indices in mice. Asian J Biochem. 2009;4(1):30–5.View ArticleGoogle Scholar
  51. Ejebe DE, Emudainohwo JOT, Ozako TC, Siminialayi IM, Esume CO, Maduadi UV. An investigation into the antiplasmodial effect of the ethanol extract of the leaves of Heliamthus annus in Swiss albino mice. Glob J Pharmacol. 2011;5(2):92–6.Google Scholar
  52. Tesfaye WH, Alamneh E. In vivo antimalarial activity of the crude extract and solvent fractions of the leaves of Zehenria scabra (Cucarbitacene) against Plasmodium berghei in mice. J Med Plant Res. 2014;8(42):1230–6.Google Scholar
  53. Muzemil A. Determination of artemisinin and essential oil contents of Artimisia annua L. grown in Ethiopia and in vivo antimalarial activity of its crude extracts against Plasmodium berghei in mice. MSc thesis. Ethopia: Addis Ababa University, Department of Pharmaceutical Chemistry; 2008.Google Scholar

Copyright

© Girma et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement